Topical Calcineurin Inhibitors (e.g., Tacrolimus, Pimecrolimus)

Type: drug

Status: FDA Approved (for other conditions, widely used off-label for OLP)

Developer: Various pharmaceutical companies

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026